product Image

TOP

DiaPlexQ™ Influenza Virus A/B Detection Kit (Respiratory Disease)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125217
Product Name
DiaPlexQ™ Influenza Virus A/B Detection Kit (Respiratory Disease)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexQ™ Influenza Virus A/B Detection Kit

Real-Time OneStep RT-PCR based assay system for simultaneous detection of influenza virus A and B

CE-IVD


Influenza is a family of RNA enveloped viruses that affects mammals and birds. Among three types of influenza viruses A, B and C. Influenza A is the most important in human infection. Influenza is a huge public health concern that occur in Seasonal epidemic and has caused pandemic level infections. There are three types of influenza viruses; A, B and C. In which specificity is conferred by internal nucleoprotein and matrix protein antigens. Influenza A and B are the major Causative agents of human acute respiratory disease worldwide, while Influenza virus C occurs much less frequently than A and B, That is why only influenza A and B are included in seasonal influenza vaccines.




Specification


DiaPlexQ™
Influenza Virus A/B Detection kit

Detection targetInfluenza Virus A , Influenza Virus B
RegistrationCE-IVD
Detection technologyReal-Time OneStep RT-PCR
Specimen typeNasopharyngeal swab, Nasopharyngeal aspirate, Bronchoalveolar lavage (BAL), Nasal swab, Oropharyngeal swab, Sputum
Analytical sensitivity10 - 10² copies
Compatible instruments*ABI 7500 / 7500 Fast Real-Time PCR System (Applied Biosystems)
CFX96™ Real-Time PCR System (BioRad)

PCR running time~ 3 hrs




Features

- Simple & Rapid detection system : OneStep Multiplex qRT-PCR (or RT-PCR) based detection

- HotStart PCR system : Ultra high specific and sensitive result

- Reliable system : Automatic PCR control & Internal control ( DiaPlexQ ™ : only PCR control)

- Positive control included

- CE certification




Experimental


Sample typeFAMCy5Texas Red / Cal Red 610Result
Positive Control+++Valid
Negative Contro--+Valid
NTC (Non-Template Control)--+Valid
Sample case 1+-+/-Influenza A
Sample case 2-++/-Influenza B
Sample case 3+++/-Influenza A&B (Co-infection)
Sample case 4--+Negative
Sample case 5---Required re-experiment



LaneInterpretation (detection)
1Negative
2Influenza Virus A
3Influenza Virus B
4NTC
5Required re-experiment



Citation&Papers

Fouchier RAV, Munster A, Wallenstein TM, Bestebroer S, Herfst D, Smith GF, et al.

J Virol. 2002;79:2814-2822

Lamb RA, Krug R. Field Virology, third ed.

Lippincott-Raven Philadelphia. 1996; 1353-1395.

Ha Y, Stevens, DJ, Wiley DC.

The EMBO Journal. 2002;21;865-875.

Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, Ha Y, et al.

Virology. 2004;287-296.





Ordering information

TechnologyCat. No.ProductContents


Real-Time PCR
SQD42-K020 (20 reaction)
DiaPlexQ ™ Influenza Virus A/B Detection kit
OneStep qRT-PCR Enzyme mix (Inf A/B)
2X OneStep qRT-PCR Buffer (Inf A/B)
Primer & Probe Mixture (Inf A/B)
Control Template (Inf A/B)
RNase free Water
SQD42-K100 (100 reaction)



Conventional (End-point) PCR
SMD42-K020 (20 reaction)

DiaPlexC ™ Influenza Virus A/B Detection kit
OneStep RT-PCR Enzyme mix (Inf A/B)
2X OneStep RT-PCR Buffer (Inf A/B)
Primer Mixture (Inf A/B)
Standard Marker (Inf A/B)
Control Template (Inf A/B)
RNase free Water
SMD42-K100 (100 reaction)


More products
SOLGENTDiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry